ProCE Banner Activity

Oncology Biosimilars: A Primer for Clinicians

Slideset Download
Download these slides with expert recommendations on the approval and integration of oncology biosimilars for clinical practice.

Released: April 20, 2020

Expiration: April 19, 2021

No longer available for credit.

Share

Faculty

Gary Lyman

Gary Lyman, MD, MPH, FASCO, FRCP (Edin)

Co-Director, Hutchinson Institute for Cancer Outcomes Research (HICOR)
Public Health Sciences and Clinical Research Divisions
Fred Hutchinson Cancer Research Center
Professor of Medicine/Medical Oncology
University of Washington School of Medicine
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Amgen, Inc.

Faculty Disclosure

Primary Author

Gary Lyman, MD, MPH, FASCO, FRCP (Edin)

Co-Director, Hutchinson Institute for Cancer Outcomes Research (HICOR)
Public Health Sciences and Clinical Research Divisions
Fred Hutchinson Cancer Research Center
Professor of Medicine/Medical Oncology
University of Washington School of Medicine
Seattle, Washington

Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, has disclosed that he has received consulting fees from Mylan, Samsung, and Sandoz.